Antibiotics Masterclass: Comprehensive Course Of Antibiotics

Explore how bacterial cell walls form from cytoplasmic monomers through membrane transport, polymerization, and cross-linking, and how beta-lactam, glycopeptide, and lipopeptide antibiotics disrupt this process to kill bacteria.

Explore the evolution of penicillins from natural Penicillin G to acid-stable Penicillin V, anti-staphylococcal, broad-spectrum, and anti-pseudomonal penicillins, including beta-lactamase inhibitors and safety considerations.

Cephalosporins are a five-generation antibiotic class that inhibits cell-wall synthesis, evolving from gram-positive to broader gram-negative coverage and used for surgical prophylaxis. They require renal adjustment and penicillin allergy considerations.

Understand carbapenems, broad-spectrum antibiotics covering gram-positive and gram-negative bacteria. Note they are injection-only, renally excreted, and imipenem is paired with cilastatin to prevent toxic metabolites, including Pseudomonas.

Monobactams have a single beta-lactam ring and no extra rings, reducing hypersensitivity and offering an alternative in penicillin allergy. They target gram-negative bacteria, including Pseudomonas.

Administer vancomycin, a glycopeptide, intravenously due to poor oral absorption, targeting gram-positive bacteria including MRSA for serious infections and Clostridium-related colitis, while monitoring nephrotoxicity, ototoxicity, and infusion reactions.

Explore daptomycin, a lipopeptide active against vancomycin-resistant enterococci, given intravenously, with limitations in pulmonary infections and risks of myopathy, rhabdomyolysis, and CPK monitoring, especially with statins.

Aminoglycosides enter gram-negative bacteria via an oxygen-dependent carrier, inhibit the 30S subunit, and are used for gram-negative infections, gut sterilization before surgery, and endocarditis synergy, with nephrotoxic and ototoxic risks.

Macrolides such as erythromycin, azithromycin, and clarithromycin treat upper respiratory infections and certain sexually transmitted infections by targeting gram-positive, gram-negative, and atypical bacteria.

Explore tetracyclines like doxycycline and minocycline, their broad spectrum against MRSA, gram-positive, gram-negative, and atypical bacteria, acne, Lyme disease, and H. pylori, with safety interactions and contraindications.

Describe glycylcyclines, notably tidey cycling, as minocycline derivatives with broad spectrum against Mersa, negatives, atypicals, and anaerobes, not active against Pseudomonas or Proteus, given intravenous use and tetracycline-like adverse effects.

Chloramphenicol has broad activity against gram-positive, gram-negative, atypical, and anaerobic bacteria, but its use is limited by serious adverse effects like bone marrow suppression and grey baby syndrome.

Explore lincosamides, especially clindamycin, active against gram-positive cocci and anaerobes, used for joint, bone, and ent infections, not treating Clostridium difficile and may cause colitis.

Use Linezolid as a last-resort oxazolidinone for resistant gram-positive cocci, including penicillin-resistant and methicillin-resistant staphylococci, streptococci, and enterococci, vancomycin-resistant strains; prolonged use risks myelosuppression, optic neuritis, and MAOI antidepressant interactions.

Explore sulfonamide antibiotics and how they disrupt bacterial folic acid synthesis, pair with trimethoprim in cotrimoxazole, and apply in urinary tract infections, malaria, toxoplasmosis, and Pneumocystis pneumonia.

Explore quinolones, four generations of antibiotics that inhibit two enzymes and DNA synthesis, targeting urinary, respiratory, and sexually transmitted infections, with notable adverse effects.

Nitroimidazoles, including metronidazole, target anaerobic bacteria and treat gingivitis, periodontitis, intra-abdominal infections, abscesses in lungs, liver, or brain, pelvic inflammatory disease, and Clostridium difficile, with off-label Crohn's disease use.

Explore quinolines: bacteria-static molecules inhibiting DNA replication enzymes. Learn about hydroxychloroquine derivatives—chloroquine, mefloquine, malarone—for malaria and certain autoimmune diseases, with hypersensitivity, liver disease, optic neuropathy, neurotoxicity, and cardiac toxicity.

Nitrofurans are antibiotics with unclear action that disrupt bacterial carbohydrate metabolism essential for DNA, RNA and protein synthesis, and concentrate in urine to treat urinary tract infections, causing tremors.

Explore thiazolides, a broad-spectrum antibiotic that inhibits an anaerobic metabolism enzyme and treats pathogens including ameba, trichomonas, giardia, and cryptosporidium, with safety for hospitalized patients.

Rifamycins inhibit RNA synthesis by binding DNA-dependent RNA polymerase, notably rifampicin, targeting mycobacteria and bacteria; they induce hepatic enzymes, cause red body fluids, and require combination therapy due to resistance.

Examine the isoniazid in the anti mycobacterial set, the most effective agent against active and latent tuberculosis, working by inhibiting cell wall, DNA, RNA, and protein synthesis and cellular metabolism.

Rifaximin, a rifampicin derivative among ansamycins that inhibits RNA synthesis, is used for traveler's diarrhea and to prevent hepatic encephalopathy by modulating gut microbiota with lactulose.

Fusidic acid inhibits RNA synthesis, acting bacteriostatic at doses and bactericidal at higher concentrations against gram-positive staphylococci; it treats skin infections, with oral use limited by side effects and interactions.

Assess whether infection is bacterial using fever and CBC indicators. Guide antibiotic choice by patient factors, route, dose, duration, and empirical therapy per guidelines.

Explores guidelines for respiratory tract infections, covering otitis media, pharyngitis, sinusitis, acute bronchitis, and pneumonia. Outlines amoxicillin dosing with and without clavulanic acid, and penicillin allergy alternatives such as azithromycin.

Explore urinary tract infections, including acute cystitis, acute pyelonephritis, and prostatitis, detailing causative organisms and antibiotic options from cotrimoxazole to fluoroquinolones and beta-lactams.

Explore gastrointestinal tract infections, diagnose via stool analysis, and apply targeted therapies—from triple, sequential, concomitant, and hybrid regimens for H. pylori to bismuth quadruple options, traveler’s diarrhea, and cholera management.